Clinical Trial Update: Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or Xalacom [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficiency of the XAL-EASE device in glaucoma and ocular hypertension patients previously treated with Xalatan or Xalacom.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Xalacom (latanoprost/timolol)
• Xalatan (latanoprost)

Snippet

Sponsor: Meir Medical Center | Conditions: Glaucoma, Hypertension | Phase 4 | Status: UNKNOWN